These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25723494)

  • 1. Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
    Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA;
    PLoS One; 2015; 10(2):e0118608. PubMed ID: 25723494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA;
    Clin Infect Dis; 2010 Mar; 50(6):920-9. PubMed ID: 20146627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
    Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
    Scott J; Underwood J; Garvey LJ; Mora-Peris B; Winston A
    Br J Radiol; 2016; 89(1060):20150979. PubMed ID: 26954329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.
    Winston A; Puls R; Kerr SJ; Duncombe C; Li PC; Gill JM; Taylor-Robinson SD; Emery S; Cooper DA;
    HIV Med; 2012 Apr; 13(4):245-51. PubMed ID: 22151608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
    Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
    BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Introduction of cART Reverses Brain Aging Pattern in Well-Controlled HIV Infection: A Comparative MR Spectroscopy Study.
    Boban JM; Kozic DB; Brkic SV; Lendak DF; Thurnher MM
    Front Aging Neurosci; 2018; 10():329. PubMed ID: 30405398
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
    Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G
    J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    Banakar S; Thomas MA; Deveikis A; Watzl JQ; Hayes J; Keller MA
    J Magn Reson Imaging; 2008 Apr; 27(4):710-7. PubMed ID: 18383256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
    Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
    Garvey LJ; Pavese N; Ramlackhansingh A; Thomson E; Allsop JM; Politis M; Kulasegaram R; Main J; Brooks DJ; Taylor-Robinson SD; Winston A
    PLoS One; 2012; 7(7):e38980. PubMed ID: 22808022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
    Keller MA; Venkatraman TN; Thomas MA; Deveikis A; Lopresti C; Hayes J; Berman N; Walot I; Ernst T; Chang L
    Neurology; 2006 Mar; 66(6):874-9. PubMed ID: 16567705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
    Liu Y; Cai ZL; Xue S; Zhou X; Wu F
    J Clin Neurosci; 2013 Apr; 20(4):548-53. PubMed ID: 23406880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.